Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Frontiers in Immunology
|
July 3, 2024
Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer
Annalise G Abbott, Daniel E Meyers, Golpira Elmi-Assadzadeh, et al.
JAMA Network Open
|
January 18, 2024
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
Sarah Cook, Vanessa Samuel, Daniel E Meyers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity
Mallik Greene, Brad Stieber, A Burak Ozbay, et al.
Cancer Medicine
|
March 16, 2021
Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
Michael S Sander, Igor Stukalin, Isabelle A Vallerand, et al.
Gastroenterology
|
December 19, 2021
Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996-2030)
Igor Stukalin, Newaz Shubidito Ahmed, Adam M Fundytus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy
Jenny J Ko, Brandon Bernard, Ben Tran, et al.
JAMA Network Open
|
December 8, 2022
Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
Alexander S Watson, Siddhartha Goutam, Igor Stukalin, et al.
Cancers
|
November 6, 2019
The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors
Daniel E Meyers, Igor Stukalin, Isabelle A Vallerand, et al.
JTO Clinical and Research Reports
|
April 24, 2023
Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors
Daniel E Meyers, Meghann Pasternak, Samantha Dolter, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
Domen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Frontiers in Immunology
|
July 3, 2024
Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer
Annalise G Abbott, Daniel E Meyers, Golpira Elmi-Assadzadeh, et al.
JAMA Network Open
|
January 18, 2024
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
Sarah Cook, Vanessa Samuel, Daniel E Meyers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity
Mallik Greene, Brad Stieber, A Burak Ozbay, et al.
Cancer Medicine
|
March 16, 2021
Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
Michael S Sander, Igor Stukalin, Isabelle A Vallerand, et al.
Gastroenterology
|
December 19, 2021
Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996-2030)
Igor Stukalin, Newaz Shubidito Ahmed, Adam M Fundytus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2016
Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy
Jenny J Ko, Brandon Bernard, Ben Tran, et al.
JAMA Network Open
|
December 8, 2022
Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
Alexander S Watson, Siddhartha Goutam, Igor Stukalin, et al.
Cancers
|
November 6, 2019
The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors
Daniel E Meyers, Igor Stukalin, Isabelle A Vallerand, et al.
JTO Clinical and Research Reports
|
April 24, 2023
Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors
Daniel E Meyers, Meghann Pasternak, Samantha Dolter, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
Domen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
Page
of 4